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Abstract				 Euplotes	raikovi	is	a	unicellular	protozoan	that	has	developed	a	complex	network	of	protein	pheromones	used	in	self-non-self	recognition	among	mating	types	of	the	species.	Members	of	the	Er-pheromone	family	are	small,	between	38-51	amino	acids,	disulfide-rich	proteins	with	a	characteristic	up-down-up	three-helix	bundle.	Er-23	is	the	largest	member	of	the	family	with	51	amino	acids,	10	of	which	are	cysteine	that	participate	in	the	formation	of	5	individual	disulfide	bonds.	The	amino	acid	sequences	participating	in	the	up-down-up	helix	architecture	have	been	computationally	predicted	to	form	beta-sheet	secondary	structure.			 This	project	seeks	to	use	Er-23	as	a	model	for	investigating	the	relationship	between	protein	structure,	stability,	and	amino	acid	sequence—an	important	topic	in	the	design	of	medically	useful	proteins.	The	Anfinsen	hypothesis	holds	that	amino	acid	sequence	determines	native	protein	conformation,	driven	by	thermodynamic	forces.	However,	Luporini	and	Wüthrich	hypothesize	that	the	disulfide	bonds	of	Er-23	maintain	the	helix	architecture	despite	computational	prediction	of	exclusive	beta-sheet	structure	presence.		Here	we	describe	the	heterologous-expression	of	Er-23	in	Escherichia	coli	and	its	characterization	using	a	variety	of	methods,	including	the	development	of	an	NMR-based	protein	concentration	estimation	technique.	We	intend	to	solve	a	highly	constrained	NMR	solution	structure	of	heterologous	Er-23	for	comparison	with	the	homologous	Er-23	structure	previously	solved	using	natural	abundance.	Additionally,	we	describe	the	investigation	of	the	role	of	individual	disulfide	bonds	in	the	structure	
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and	stability	of	heterologously-expressed	Er-23	through	the	replacement	of	each	cysteine	disulfide	pair	with	both	Ala-Val	and	Val-Ala	mutations.	Analysis	of	Cys-free	mutant	structure	and	stability	will	be	completed	by	comparison	of	wild-type	Er-23	using	both	CD	and	NMR	studies.	We	also	intend	to	study	disulfide	importance	by	performing	the	famous	Anfinsen	reversible	denaturation	experiment	using	heterologous	Er-23.		Preliminary	results	from	CD	and	NMR	studies	suggest	that	Er-23	is	adopting	the	wild-type	fold	when	expressed	in	the	cytoplasm	of	E.	coli.	Expression	and	purification	of	Cys-free	mutants	has	been	partially	completed	with	successful	results.			 	
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Chapter	1	
	Introduction	
1.1:	Protein	Structure		An	understanding	of	protein	structure	is	a	critical	tool	in	the	biochemist’s	toolbox.	A	protein,	in	its	most	simple	form,	is	a	string	of	amino	acids	connected	by	peptide	bonds.	Knowing	the	primary	structure	of	a	protein	is	not	particularly	useful	when	investigating	the	role	of	a	protein	in	a	biological	system.	It	is	only	when	the	protein	begins	to	fold	and	assume	its	secondary	and	tertiary	structure	that	it	becomes	biologically	active.	Disturbances	in	the	native	or	active	structure,	resulting	in	some	degree	of	denaturation,	can	cause	a	protein	to	lose	its	function2.	Christian	Anfinsen	illustrated	the	biological	tendency	for	a	protein	to	fold	into	its	native	structure.	Anfinsen	studied	ribonuclease,	a	protein	that	contains	eight	cysteine	residues	that	form	four	disulfide	bonds	in	the	native	structure.	He	concluded	that	the	driving	force	in	the	correct	pairing	of	the	four-disulfide	bonds	was	the	interactions	of	side-chain	functional	groups	along	the	primary	structure3,4.	Through	this	work,	Anfinsen	was	the	first	to	prove	that	amino	acid	sequence	determines	conformation	and	conformation	determines	biological	activity5,6.		Knowing	how	a	protein	folds	into	its	tertiary	structure	is	an	important	step	in	understanding	how	structure	meets	function.	Cyrus	Levinthal	was	one	of	the	original	biochemists	to	suggest	that	a	protein	follows	a	certain	folding	pathway	to	reach	its	native	structure.	He	hypothesized	that	local	interactions	and	condensations	of	portions	of	a	folding	protein	followed	a	well-defined	sequence	of	events	in	nature7.		
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Levinthal	later	developed	what	is	known	as	the	Levinthal	Paradox,	which	states	that	the	folding	interactions	of	a	protein	cannot	be	random2.	Mathematical	analysis	of	a	relatively	small	protein	consisting	of	101	amino	acids	reveals	an	astounding	5x1047	possible	unique	conformations.	Even	given	an	incredible	sampling	rate,	random	searches	for	a	correct	tertiary	structure	could	take	many	years.	Zwanzig	showed	that	by	imposing	an	energetic	bias	for	a	correct	conformation,	the	folding	process	is	mathematically	shortened	to	a	biologically-relevant	time	scale8.		The	protein	folding	sequence	follows	a	path	to	reach	a	most	thermodynamically	favorable	conformation.	This	is	not	to	say	that	the	native	tertiary	structure	is	the	most	favorable/	lowest	energy	state.	It	is	the	lowest	free-energy	state	among	conformations	not	confined	behind	high	free-energy	barriers9,10.		The	combined	efforts	of	Anfinsen	and	Lenvinthal	can	summarized	as	the	hypothesis	of	thermodynamic	control	of	protein	folding10.	The	contributions	of	these	biochemistry	pioneers	have	allowed	for	a	more	clear	understanding	of	the	process	of	protein	folding.	However,	the	prediction	of	the	tertiary	structure	of	a	protein	from	the	primary	structure	remains	elusive.		
1.2:	Disulfide	Bonds	Disulfide	bonds	in	proteins	are	formed	by	the	reversible	oxidative	condensation	of	thiol	groups	in	two	cysteine	residues.	The	result	is	a	covalent	bridge	between	cysteine	residues	close	in	space	but	not	necessarily	in	primary	structure.	Disulfide	formation	is	typically	sequestered	in	an	oxidative	environment	favorable	to	the	reaction.	This	corresponds	to	the	endoplasmic	reticulum	in	eukaryotes	and	the	
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periplasm	in	prokaryotes.	Additionally,	protein	disulfide	isomerases	(PDI)	and	disulfide	bond	proteins	(Dsb	proteins)	assist	in	the	disulfide	formation11.	Reducing	environments,	such	as	the	prokaryotic	cytoplasm,	oppose	the	formation	of	disulfide	bonds.	The	periplasm	of	Escherichia	coli	has	a	reducing	potential	much	lower	than	its	cytoplasm,	which	helps	explain	the	need	to	isolate	disulfide	formation	to	the	periplasm12.	The	formation	of	stable	disulfides	in	the	cytoplasm	is	an	extremely	rare	event	in	nature13.	Proteins	with	structural	disulfides	are	confined	to	non-cytosolic	intracellular	compartments	or	are	located	extracellularly13.	The	difficulty	in	forming	disulfide	bonds	in	prokaryotic	organisms	is	a	not	futile	effort.	While	an	oxidized	thiol	pair	is	not	particularly	beneficial	within	the	cytoplasm,	it	can	be	advantageous	for	extracellular	proteins.	In	some	extracellular	proteins,	disulfide	bonds	are	important	for	correct	folding	or	functionality11,12.	Another	benefit	disulfides	provide	is	increased	stability	in	a	hostile	extracellular	environment.	The	introduction	of	a	new	covalent	bond	places	a	conformational	constraint	on	the	protein	backbone14.	This	has	a	negative	effect	on	the	entropy	of	the	denatured	state,	which	makes	the	native	state	more	preferable11,14.	The	thermodynamic	effect	of	the	disulfide	on	the	protein	increases	the	protein’s	stability	with	respect	to	high	temperatures,	extreme	pH,	and	high	concentrations	of	organic	solvents14.		The	stability	provided	by	disulfide	bonds	will	subsequently	improve	proteins’	resistance	to	proteolytic	degradation	and	oxidants	encountered	extracellularly.	The	collective	result	of	the	stability	benefits	provided	by	disulfide	bonds	is	an	increased	protein	half-life11,14.	Half-life	of	a	secreted	protein	is	critical	as	it	provides	a	measure	of	how	long	the	protein	provides	its	beneficial	function	to	the	organism.		
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The	benefit	effects	are	not	confined	only	to	wild-type	proteins	containing	disulfide	bonds.	The	possibility	of	engineering	a	disulfide	bond	in	a	protein	has	been	illustrated	by	studies	on	a	variety	of	proteins.	An	engineered	disulfide	increased	the	thermostability	of	pyroglutamyl	peptidase	I	and	Rhizomurcor	miehei	lipase	over	their	wild-type	counterparts15,16.	Both	the	half-life	and	thermostability	of	a	tetrameric	malate	dehydrogenase	from	Choloroflexus	aurantiacus	were	increased	when	a	disulfide	bond	was	introduced17.	The	folding	of	disulfide-containing	proteins	is	a	more	complicated	process	that	that	of	a	typical	protein.	Their	folding	requires	the	concerted	force	of	non-covalent	bonds	within	the	sequence	of	amino	acids	channeling	the	protein	folding	process	with	the	formation	of	the	covalent	disulfide	linkage.	The	term	describing	this	phenomenon	is	“oxidative	folding”	and	several	models	have	been	developed.	Some	proteins	require	the	preliminary	formation	of	disulfide	bonds	in	the	unfolded	state	to	limit	the	search	in	conformational	space	as	the	protein	backbone	folds	into	its	correct	tertiary	structure.	The	need	for	folding	catalysts	such	as	PDIs	to	shuffle	non-native	disulfides	in	this	oxidative	folding	model	has	been	suggested11.	This	model	highlights	the	importance	of	disulfides	reducing	conformational	entropy	to	help	guide	protein	folding.	Work	on	other	proteins	has	demonstrated	a	different	model	of	oxidative	folding.	In	this	model,	the	conformational	folding	of	the	protein	backbone	into	its	tertiary	structure	is	followed	by	the	formation	of	disulfide	bonds11.	This	model	highlights	the	importance	of	the	primary	structure	to	guide	protein	folding	and	orient	the	appropriate	residues	in	physical	space	such	that	the	disulfide	bonds	can	be	formed.			
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1.3:	Pheromone	Er-23	
	 Pheromone	Er-23	is	a	member	of	a	structurally	homologous	group	of	pheromones	produced	by	protozoan	Euplotes	raikovi	used	for	autocrine	growth	and	paracrine	mating	signals18,19.	The	collection	of	Er-pheromones	is	special	due	to	all	the	members	being	small	(38-15	amino	acids),	disulfide-rich	proteins1,20.	Er-23	is	a	deviant	member	of	known	Er-pheromones	due	to	its	increased	size,	number	of	disulfide	bonds,	and	three-dimensional	structure.	The	Er-23	protein	is	assembled	of	51	amino	acid	residues,	and	contains	five	helical	structures.	Ten	of	its	residues	are	cysteine,	which	participate	in	the	formation	of	five	specific	disulfide	bonds	in	the	native	structure1.			 Er-23	contains	a	three-helix	bundle	architecture,	arranged	in	an	antiparallel	up-down-up	arrangement,	common	to	all	Er-pheromones.	The	helix	bundle	forms	a	highly	compacted	core	where	only	10%	or	less	of	the	surface	area	of	core	residues	is	solvent-accessible1.	Also	common	to	all	Er-pheromones,	protein	secondary	structure	prediction	of	Er-23	suggests	the	exclusive	presence	of	beta-sheet	secondary	structure	in	the	segments	composing	the	four	alpha	helices.	It	has,	thus,	been	predicted	that	three	of	the	disulfide	bonds	in	Er-23	stabilize	and	enforce	the	characteristic	up-down-up	helix	bundle	in	the	compacted	core1.		
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Figure	1.1:	[1H,1H]-2QF-COSY	NMR	spectrum	of	homologously	expressed	Er-231	
	
		 The	NMR	solution	structure	has	been	previously	solved	for	Er-pheromones	following	purification	from	the	native	organism	and	13C	assignments	using	natural	abundance1.			
	
Figure	1.2:	Stereo	views	of	Er-23	NMR	structure	calculation1	
		 Temperature-induced	denaturation	studies	on	Er-23	using	circular	dichroism	has	been	completed	following	purification	from	E.	raikovi21.	It	was	concluded	that	WT	
	  7	
Er-23	was	the	most	stable	of	the	Er-pheromones	as	it	was	not	denatured	when	heated	to	95°C.	 	
	
Figure	1.3:	Thermal	melt	CD	spectra	of	homologously	expressed	Er-2321	Previous	work	in	the	Magliery	lab	has	prepared	the	Er-23	gene	for	expression	in	
Escherichia	coli	and	began	the	characterization	via	circular	dichroism	experiments	of	wild-type	Er-23	expressed	in	E.	coli22.	This	preliminary	work	has	alluded	to	the	high	stability	and	native	folding	of	Er-23	expressed	in	E.	coli.	Circular	dichroism	spectra	of	Er-23	from	E.	coli	show	a	significant	peak	at	209	nm,	indicating	the	presence	of	disulfide	bonds	and	alpha-helical	structure.			
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Figure	1.4:	CD	spectrum	of	heterologously	expressed	Er-2322	
		When	acquiring	thermal	melt	data,	the	CD	signal	at	222	nm	remained	relatively	unchanged	then	Er-23	was	heated	to	95°C.	CD	spectra	of	Er-23	samples	before	and	after	thermal	melts	showed	that	the	samples	subjected	to	95°C	maintained	the	spectra	of	unheated	samples22.		
1.4:	Expression	and	Purification	of	Disulfide-rich	proteins	in	Escherichia	coli	In	the	initial	stages	of	the	Er-23	project,	it	was	decided	that	we	would	express	and	purify	Er-23	from	E.	coli	cells,	a	heterologous	organism.	This	was	decided	out	of	convenience	rather	than	practicality.	Previous	work	outside	of	the	Magliery	lab	expressed	and	purified	Er-23	from	its	native	organism,	Euplotes	raikovi19,23.	Therefore,	an	expression	strategy	had	to	be	designed	before	characterization	of	Er-23	could	begin.	As	discussed	in	section	1.2,	disulfide	bond-containing	proteins	are	not	often	found	in	the	cytoplasm	of	E.	coli.		
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The	thiol-disulfide	redox	potential	of	the	cytoplasm	of	E.	coli	is	too	low	to	provide	a	driving	force	for	the	formation	of	disulfide	bonds13.		The	cytoplasm	has	a	reducing	redox	potential	of	-240	mV	to	-270	mV,	where	as	the	periplasm	is	more	oxidizing	environment	at	-0.165	mV24.	Additionally,	there	are	no	active	enzymes	that	catalyze	thiol-oxidation	in	the	cytoplasm	of	E.	coli13.	However,	the	Bessette	lab	developed	a	fast-growing	E.	coli	strain	with	null	mutations	at	the	trxB	and	gor	loci13.	These	genes	are	responsible	for	products	that	maintain	cytoplasmic	thioredoxins	and	glutaredoxins	in	a	reduced	state.	In	the	absence	of	these	genes,	thioredoxins	and	glutaredoxins	are	in	an	oxidized	state	and	can	catalyze	the	formation	of	protein	disulfide	bonds.	The	trxB	and	gor	mutant	has	a	cytoplasmic	thiol-disulfide	redox	potential	suitable	for	disulfide	formation13,24.		The	cytolasmic	thiol-disulfide	redox	potential	of	the	double	mutant	created	by	Bessette	was	intermediate	that	of	the	typical	periplasm	and	cytoplasm,	which	allows	for	slow	disulfide	bond	formation	kinetics	in	comparison	to	in	the	periplasm.	The	slower	oxidation	rate	is	favorable	for	disulfide-rich	proteins	because	it	the	disulfide	formation	is	more	heavily	influenced	by	conformational	preferences	of	the	amino	acid	sequence13.	
1.5:	Synthesis	of	Cysteine-free	proteins		 The	removal	cysteine	residues	is	a	topic	of	interest	in	the	Magliery	lab.	Cysteine	residues	can	complicate	the	folding	because	the	formation	of	disulfide	bonds	can	be	a	slow	step.	Additionally,	cysteine	residues	can	be	problematic	for	the	storage	of	proteins	in	vitro	because	the	oxidation	of	cysteine	residues	can	lead	to	misfolding	or	oligimerization	instead	of	the	formation	of	correct	disulfide	bonds25.	Lastly,	cysteine	removal	can	improve	the	protein’s	expression	in	E.	coli26.	Previous	work	in	cysteine	
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removal	in	the	Magliery	lab	has	focused	on	constructing	a	Cys-free	variant	of	Rop,	a	well-characterized	protein.			 After	deciding	to	remove	cysteine	residues,	the	question	then	becomes	which	amino	acids	should	be	substituted	for	cysteine.	The	strategy	is	to	find	residues	that	could	replace	the	cysteine	pair	and	best	conserve	the	structure	of	the	native	protein.	When	constructing	the	Cys-free	Rop	variant,	it	was	decided	to	substitute	in	a	serine	pair,	alanine	pair,	valine	pair,	or	alanine/valine	pair.	The	function	of	Rop	in	E.	coli	cells	is	to	control	the	copy	number	of	ColE1	plasmid	number.	Activity	of	Rop	variants	can	be	assessed	using	a	GFP	screen	that	links	the	expression	of	green	fluorescent	protein	with	the	ColE1	plasmid	copy	number27.	The	activities	of	the	Cys-free	Rop	variants	were	compared	to	wild-type	Rop	in	the	GFP	screen	to	determine	the	variants	that	most	closely	represented	wild-type25.		
	
Figure	1.5:	In	vivo	activity	screen	of	Cys-free	Rop	variants25	Despite	both	the	Ala/Ala	and	Val/Val	variants	being	active,	only	the	Ala/Ala	variant	could	be	expressed	at	significant	levels	using	the	T7	promoter25.	The	screen	
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showed	that	the	Ala/Val	variant	had	activity	most	similar	to	wild-type,	and	had	similar	helical	structure	as	determined	by	CD.	Interestingly,	the	Ala/Val	variant	had	increased	thermal	stability	over	wild-type.			 The	findings	of	Cys-free	Rop	study	formed	the	basis	for	disulfide	removal	in	Er-23.	Previous	work	in	the	Magliery	lab	has	begun	to	replace	Cys/Cys	pairs	of	Er-23	disulfide	bonds	with	Ala/Val	or	Val/Ala	pairs	to	determine	which,	if	any,	of	the	disulfide	bonds	are	needed	for	the	correct	folding	and	stability	of	Er-2322.	These	findings	will	allow	us	to	determine	the	level	of	contribution	of	disulfides	in	the	structure	and	properties	of	Er-23.	
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Chapter	2	
Objectives	
2.1:	Synthesis	and	Characterization	of	WT	Er-23	
The	primary	goal	of	this	project	is	to	successfully	express	WT	Er-23	pheromone	in	E.	coli.	This	work	has	been	previously	begun	by	Venuka	Durani28	and	later	continued	by	Kiersten	Lessig22.	Characterization	will	continue	using	an	Er-23-pHLIC	plasmid	(created	by	Venuka	Durani28)	maintained	in	DH10B	DE3	E.	coli	and	expression	in	Origami	DE3	E.	coli.	Following	optimized	expression	and	purification	of	WT	Er-23,	characterization	via	NMR,	crystallography,	and	CD	thermal	melts	will	be	performed.	
2.2:	Synthesis	and	characterization	of	Er-23	Cys-free	variants	
	 Our	secondary	goal	of	this	project	is	to	study	the	implications	of	disulfide	bond	removal	in	Er-23.	The	first	step	of	synthesizing	cys-free	Er-23	variants	involves	the	replacement	of	cysteine	residues	participating	in	individual	disulfide	bonds	with	Ala/Val	or	Val/Ala	pairs.	This	work	has	been	partially	completed	by	Kiersten	Lessig	of	the	Magliery	Lab22.	We	will	then	work	towards	successful	expression	and	purification	of	these	variants	similar	to	WT	Er-23.	Characterization	of	the	successfully	purified	cys-free	variants	via	CD	thermal	melts	and	other	studies	will	be	performed	to	analyzed	variant	stability	and	structure	in	comparison	to	WT	Er-23.	
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Chapter	3	
Materials	&	Methods	
3.1:	Synthesis	of	WT	Er-23	and	Cys-free	variants	
Gene	Construction	
	 Methods	of	overlap	PCR	were	used	for	assembly	of	gene	fragments,	and	the	reactions	were	performed	using	an	Eppendorf	thermal	cycler.	The	WT	Er-23	genes	were	synthesized	from	four	primers	(sequences	shown	in	Table	3.1).	Variant	genes	were	synthesized	from	four	primers	containing	the	specific	mutations,	which	replaced	a	specific	disulfide	cysteine	residue	pair	with	alanine	and	valine	residues	(primers	shown	in	Table	3.2).	The	genes	were	assembled	from	two	separate	overlap	PCR	reactions.	First,	a	Klenow	reaction	was	used	to	synthesize	the	body	of	the	gene	from	the	two	respective	primers.	During	the	second	reaction,	forward	and	reverse	amplification	primers	were	used	to	amplify	the	Klenow	product.	Amplification	reactions	were	carried	out	in	a	total	volume	of	100	μL	with	an	annealing	temperature	of	60	°C	for	25	cycles	using	Pfu	polymerase.		
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Figure	3.1:	Overlap	PCR	cloning	schematic	
	
	
WT	Er-
23	 Construct	
GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGATTGCACGACCTGCTTCAATAATGGCACCGGCCCATGCGCGAATTGCCTGGCGGGCTATCC	GGCGGGGTGCAGCAATAGCGACTGTACCGCGTTTCTGAGCCAGTGCT	ATGGAGGTTGC	Amp_Fwd	 AATATTCCATGGCGAAAATTTATATTTCCAGGGCGAATGCGAACAGTGC	Amp_Rev	 ATTATAAGGATCCGTTTAGGACTTCCAATGTTAGCAACCTCCATAGCACTGGC	
WT	Er-
23	GSS
G	 Klenow_1	
GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGATTGCACGACCTGCTTCAATAATGGCACCGGCCCATGCGCGAATTGCCTGGCGGGCTATCCGGCGGGG	
Klenow_2	 GCAACCTCCATAGCACTGGCTCAGAAACGCGGTACAGTCGCTATTGCTGCACCCCGCCGGATAGCCCGCCAGGCAATTCGCGCATGGGCCGGTGCC	Amp_Fwd	 AAAATTTATATTTCCAGGGTAGTAGTGGCGAATGCGAACAGTGC	Amp_Rev	 TTATCCACTTCCAATGTTAGCAACCTCCATAGCACTG	
Table	3.1:	Primers	used	to	synthesize	WT	Er-23	constructs	
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Er-23	1
3A47V
	 Klenow_Fwd	 GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGATGCGACAACATGTTTTAACAACGGGACCGGTCCTTGCGCGAACTGTCTTGCTGGG	Klenow_Rev	 GCAACCACCATACACTTGACTCAGAAAAGCAGTACAGTCGCTATTAGAACATCCAGCCGGGTACCCAGCAAGACAGTTCGCGCAAGGACC	Amp_Fwd	 CATCATGGCCATGGCGAAAATTTATATTTACAAGGCGAATGCGAACAGTGCTTT	Amp_Rev	 AATAATAATCCGGATCCTTAGCAACCACCATACACTTG	
Er-23	1
3V47A
	 Klenow_Fwd	 GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGATGTGACCACCTGCTTTAACAACGGTACCGGTCCTTGCGCGAACTGTCTTGCTGGC	Klenow_Rev	 GCAACCACCATACGCCTGAGACAGAAAAGCAGTACAGTCACTATTACTACAACCAGCAGGATAGCCAGCAAGACAGTTCGCGCAAGGACC	Amp_Fwd	 CATCATGGCCATGGCGAAAATTTATATTTACAAGGCGAATGCGAACAGTGCTTT	Amp_Rev	 AATAATAATCCGGATCCTTAGCAACCACCATACGCCTG	
Er-23	2
7A40V
	 Klenow_Fwd	 GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGACTGTACCACCTGCTTTAACAACGGTACTGGTCCTTGTGCAAATGCTCTAGCTGGG	Klenow_Rev	 GCAGCCACCATAGCATTGAGACAGAAACGCAGTCACATCAGAGTTGCTACAACCAGCCGGATACCCAGCTAGAGCATTTGCACAAGGACC	Amp_Fwd	 CATCATGGCCATGGCGAAAATTTATATTTACAAGGCGAATGCGAACAGTGCTTT	Amp_Rev	 AATAATAATCCGGATCCTTAGCAGCCACCATAGCATTG	
Er-23	2
7V40A
	 Klenow_Fwd	 GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGATTGTACCACCTGTTTTAACAACGGTACCGGTCCTTGTGCGAACGTGCTGGCTGGG	Klenow_Rev	 GCAGCCACCATAGCACTGAGACAGAAACGCAGTCGCATCAGAGTTAGAACAGCCAGCAGGATACCCAGCCAGCACGTTCGCACAAGGACC	Amp_Fwd	 CATCATGGCCATGGCGAAAATTTATATTTACAAGGCGAATGCGAACAGTGCTTT	Amp_Rev	 AATAATAATCCGGATCCTTAGCAGCCACCATAGCACTG	Er - 2 3	 3 5 A 5 1 V	Klenow_Fwd	 GGCGAATGCGAACAGTGCTTTAGCGATGGCGGCGATTGCACCACCTGC
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TTTAACAACGGTACTGGACCATGTGCGAACTGCCTG	Klenow_Rev	 CACGCCGCCATAGCACTGACTCAGAAACGCGGTGCAATCGCTGTTGCTCGCTCCCGCTGGATATCCTGCCAGGCAGTTCGCACATGGTCC	Amp_Fwd	 ATTATTCCATGGCGAAAATTTATATTTACAGGGCGAATGCGAACAGTGC	Amp_Rev	 AATAATAATGGATCCTTACACGCCGCCATAGCACTG	
Er-23	3
5V51A
	 Klenow_Fwd	 Same	as	Er-23	35A51V	Klenow_Fwd	Klenow_Rev	 CGCGCCGCCATAGCACTGACTCAGAAACGCGGTGCAATCGCTGTTGCTCACTCCCGCTGGATATCCTGCCAGGCAGTTCGCACATGGTCC	Amp_Fwd	 Same	as	Er-23	35A51V	Amp_Fwd	Amp_Rev	 AATAATAATGGATCCTTACGCGCCGCCATAGCACTG	
Table	3.2:	Primers	used	to	synthesize	Er-23	Cys-free	variants	
Cloning	
	
Figure	3.2:	pHLIC	vector	with	Er-23	gene	
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Figure	3.3:	Er-23	protein	design	
	
	 Following	the	overlap	PCR	steps,	each	gene	insert	made	from	its	respective	four	primers	contained	an	NcoI	and	BamHI	restriction	site.	The	gene	inserts	were	then	digested	at	37	°C	for	4	hours	with	NcoI	and	BamHI	restriction	endonucleases.	These	inserts	were	then	ligated	with	pHLIC	vector	(constructed	by	Venuka	Durani,	Brandon	Sullivan,	and	Thomas	Magliery),	which	was	also	digested	at	its	NcoI	and	BamHI	restriction	sites	at	37	°C	for	4	hours	in	a	total	volume	of	50	μL.	The	ligation	reaction	of	the	digested	inserts	and	pHLIC	vector	occurred	overnight	at	16	°C	in	a	total	volume	of	5	μL.	The	vector	complete	with	a	gene	insert	was	then	transformed	via	electroporation	into	electrocompetent	DH10B	E.	coli	cells.	The	transformed	cells	were	plated	on	LB	agar	containing	100	μg/mL	ampicillin	and	incubated	at	37	°C	overnight.	The	resulting	isolated	colonies	were	picked	and	their	DNA	was	extracted	using	Qiagen	miniprep	protocol.	The	DNA	was	sequenced	via	Sanger	sequencing	by	Genewiz.		
3.2:	Expression	and	Purification	of	WT	Er-23	and	Cys-free	variants	
Expression	
	 Liquid	media	used	for	expression	was	2YT	with	100	μg/mL	ampicillin,	unless	otherwise	stated.	WT	Er-23	and	Cys-free	variant	DNA	was	transformed	into	electrocompetant	OrigamiTM	B	E.	coli	cells:	F-	ompT	hsdSB(rB-	mB-)	gal	dcm	lacY1	ahpC	
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(DE3)	gor522::	Tn10	trxB	(KanR,	TetR)	from	EMD	Millipore. The	trxB	and	gor	mutations	are	selectable	on	kanamycin	and	tetracycline,	respectively29.	These	cells	were	plated	on	LB	agar	containing	100	μg/mL	ampicillin	and	incubated	at	37	°C	overnight.	Small	25	mL	seed	cultures	of	isolated	colonies	were	grown	overnight.	The	seed	cultures	were	pitched	into	2	L	of	media	in	4	L	baffled	flasks,	which	were	grown	at	37	°C	in	a	shaker	incubator	until	reaching	OD600=0.8,	about	4	hours.	The	cultures	were	then	induced	with	0.1	mM	IPTG	during	the	log	growth	phase.	Expression	occurred	overnight	at	25	°C.	Following	expression,	the	cells	were	centrifuged	and	cell	pellet	frozen	at	-80	°C	until	purification.	 
Protein	Purification	
	 The	frozen	cell	pellet	was	resuspended	in	15	mL	of	lysis	buffer	(50mM	Tris-HCl,	300	mM	NaCl,	10	mM	imidazole,	pH	8).	To	the	resuspended	cells,	5	mM	MgCl2,	0.5	mM	CaCl2,	5	μL	of	both	DNase	I	and	RNase	A	(each	at	5	mg/ml),	and	0.1%	Triton	X-100	were	added.	The	mixture	was	then	incubated	at	4	°C	or	on	ice	for	at	least	30	minutes.	Following	the	incubation,	the	cells	were	lysed	via	an	Emulsiflex	at	a	pressure	differential	between	15,000	and	20,000	psi.	The	cell	suspension	mixture	passed	through	the	Emulsiflex	at	least	three	times	and	remained	on	ice	between	cycles.		
	 The	homogenized	cell	lysate	was	then	centrifuged	at	17,000	rpm	for	45	minutes.	The	supernatant	was	allowed	to	bind	to	1.5	mL	Ni-NTA	agarose	resin	(Qiagen)	at	4	°C	for	60	minutes	on	a	nutator.	The	mixture	was	poured	through	a	large	(20	mL)	pre-fitted	column,	and	the	flow-through	collected.	The	column	was	then	washed	with	12	mL	wash	buffer	(50mM	Tris-HCl,	300	mM	NaCl,	20	mM	imidazole,	pH	8)	and	12	mL	wash	buffer	2	
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(50mM	Tris-HCl,	300	mM	NaCl,	50	mM	imidazole,	pH	8).	Lastly,	the	column	was	eluted	with	3	mL	elution	buffer	(50mM	Tris-HCl,	300	mM	NaCl,	250	mM	imidazole,	pH	8).	
	 To	the	collected	elution	sample	was	added	0.08	mg	TEV	protease	twice;	first,	for	60	minutes	at	room	temperature	on	the	nutator	and	next,	overnight	under	the	same	conditions.	The	sample	was	then	dialyzed	back	into	lysis	buffer	using	a	2	kDa	MWCO	Slide-A-LyzerTM	(Thermofisher)	dialysis	cassette.	The	sample	was	dialyzed	twice,	each	for	60	minutes	in	1	L	lysis	buffer	at	room	temperature.		
	 The	dialyzed	sample	was	allowed	to	bind	to	1	mL	Ni-NTA	agarose	resin	for	60	minutes	at	4	°C	on	the	nutator.	After	binding,	the	sample	was	poured	through	a	small	(10	mL)	pre-fitted	column,	and	the	flow-through	collected	and	saved	as	the	cleaved	protein.	The	column	was	washed	with	12	mL	lysis	buffer	and	eluted	with	3	mL	elution	buffer.	The	cleaved	protein	could	be	optionally	concentrated	by	injecting	the	flow-through	into	a	2	kDa	MWCO	Slide-A-LyzerTM	dialysis	cassette.	The	surface	of	the	cassette	membrane	was	coated	with	Aquacide	II	(Millipore)	and	held	at	room	temperature	until	the	desired	volume	reduction	was	achieved.	Concentrated	cleaved	protein	was	removed	from	dialysis	cassette	and	stored	at	room	temperature	for	future	characterization.	
3.3:	Characterization	of	WT	Er-23	and	Cys-free	variants	
SDS-PAGE		
	 All	protein	samples	throughout	purification	were	saved.	Protein	samples	were	mixed	in	equal	volume	of	2x	SDS	loading	buffer	without	reducing	agents.	Samples	were	
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loaded,	along	with	a	protein	ladder,	into	their	respective	lanes	of	an	18%	SDS	gel.	A	gel	electrophoresis	machine	(Bio-Rad)	was	used	to	run	the	SDS	gel	at	200	V	until	the	blue	dye	band	reached	the	bottom	of	the	gel.	The	gel	was	immediately	removed	and	treated	with	various	staining	procedures.		
Silver	Staining	
	 All	staining	buffers	were	made	fresh	prior	to	use	for	best	results.	18	MΩcm	H2O	was	used	in	all	staining	buffers	and	washing	steps.	Gel	and	all	materials	used	in	staining	procedure	were	first	washed	thoroughly	with	H2O	to	remove	impurities.	The	gel	was	fixed	in	fixing	solution	(50%	methanol,	12%	acetic	acid,	H2O)	for	30	minutes.	Fixed	gel	was	washed	3x	for	10	minutes	with	50%	methanol.	The	gel	was	then	pretreated	for	1	minute	in	pretreatment	solution	(1.3	mM	Na2S2O3,	H2O),	followed	by	3x	20	seconds	washing	with	H2O.	Then	the	gel	was	nutated	in	stain	solution	(12	mM	AgNO3,	0.075%	formaldehyde,	H2O)	for	20	minutes,	then	washed	2x	30	seconds	with	H2O.	Developer	solution	(0.57M	Na2CO3,	0.05%	formaldehyde,	0.025	mM	Na2S2O3,	H2O)	was	added	to	the	gel	until	bands	appeared	on	the	gel.	The	development	was	stopped	by	transferring	gel	to	the	fixing	solution	for	10	minutes.		
MALDI-TOF	MS	
	 MALDI	matrix	(0.05%	TFA,	50%	acetonitrile,	saturated	sinapinic	acid)	was	made	fresh	immediately	prior	to	use	and	otherwise	stored	in	the	dark	at	room	temperature.	MALDI	matrix	was	mixed	in	equal	volume	with	protein	purification	samples.	No	other	treatment	of	protein	purification	samples	was	required.	The	protein-matrix	mixture	
	  21	
was	spotted	on	a	clean	MALDI	plate	in	volumes	between	0.5	μL	and	1.5	μL.	The	spotted	MALDI	plate	was	allowed	to	dry	completely	overnight	prior	to	the	MALDI	experiment.	The	experiment	was	performed	using	a	Bruker	microflex	MALDI-TOF	MS	operated	by	Sidharth	Mohan.		
Amino	Acid	Analysis	
	 Cleaved	protein	flow-through	of	WT	Er-23	GSSG	was	submitted	to	Jinny	Johnson,	M.S.	of	Texas	A&M	University	for	amino	acid	analysis.	The	flow-through	sample	was	dialyzed	into	Er-23	storage	buffer	(50mM	phosphate,	50mM	NaCl,	pH	6)	using	a	2	kDa	MWCO	Slide-A-LyzerTM	dialysis	cassette	to	remove	the	Tris	buffer.	The	dialyzed	sample	was	concentrated	using	Aquacide	II	(Millipore)	as	described	earlier.	The	concentration	was	adjusted	to	1	mg/mL	based	on	concentration	estimation	of	the	cleaved	6xHis	tag	in	the	TEV	cleaved	sample	lane	on	an	18%	Coomassie-stained	SDS	gel.	
1D	NMR	
	 Cleaved	protein	flow-through	sample	of	WT	Er-23	GSSG	(from	same	purification	as	used	in	amino	acid	analysis)	was	dialyzed	into	Er-23	storage	buffer	using	a	2	kDa	MWCO	Slide-A-LyzerTM	dialysis	cassette	to	remove	imidazole	and	Tris.	Then	the	dialyzed	sample	was	concentrated	using	Aquacide	II	(Millipore)	as	described	earlier.	The	sample	was	Pasteur	pipetted	into	an	NMR	tube	as	a	mixture	of	90%	concentrated	cleaved	protein	flow-through	and	10%	D2O.	The	NMR	scans	were	acquired	and	analyzed	by	David	Bowles	of	the	Magliery	Lab.		
3D	NMR	
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	 The	expression	and	purification	was	conducted	as	described	earlier,	except	rich	2YT	media	was	replaced	with	Neidhart’s	minimal	media	(1x	Neidhart’s	solution,	19	mM	NH4Cl,	1.32	mM	K2HPO4,	10	mM	NaHCO3,	50mg/L	thiamine,	17	mM	glucose,	18	MΩ/cm2	H2O).	15N-labeled	NH4Cl	was	used	as	the	nitrogen	source	and	13C-labeled	glucose	was	used	as	the	carbon	source.	To	the	Neidhart’s	minimal	media	was	added	100	μg/mL	ampicillin	and	30	μg/mL	Kanamycin	(final	concentrations)	prior	to	inoculation.	The	concentrated	cleaved	protein	sample	dialyzed	into	Er-23	storage	buffer	was	Pasteur	pipetted	into	a	clean	NMR	tube	with	10%	D2O.	The	NMR	scans	were	acquired	and	analyzed	by	David	Bowles	of	the	Magliery	Lab.		
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Chapter	4	
Results	
4.1:	Synthesis	and	Characterization	of	WT	Er-23	
	 Previous	work	on	the	protein	outside	the	Magliery	lab	chose	to	express	and	purify	Er-23	directly	from	Euplotes	raikovi.	Given	the	unusual	demands	of	culturing	
Euplotes	raikovi,	it	was	decided	we	would	use	Escherichia	coli,	the	standard	organism	used	in	the	Magliery	lab,	in	the	expression	of	Er-23.	This	required	that	we	first	synthesize	the	Er-23	gene	such	that	it	could	be	expressed	in	E.	coli.		
The	first	challenge	in	synthesizing	WT	Er-23	was	to	decide	the	expression	scheme.	Our	selected	expression	scheme	had	to	reflect	its	unique	composition	of	amino	acids,	almost	one-fifth	of	them	being	cysteine	residues.	All	10	of	the	cysteine	residues	participate	in	the	formation	of	5	specific	disulfide	bonds	in	the	native	structure.	The	expression	scheme	selected	must	create	conditions	under	which	the	formation	of	the	disulfide	bonds	in	the	native	structure	would	be	possible.	Typically,	proteins	with	disulfide	bonds	are	expressed	in	the	cell	periplasm,	where	the	reduction	potential	is	amiable	to	thiol	oxidation.	Additionally,	the	periplasm	contains	foldases,	DsbA	and	DsbC,	which	catalyze	the	formation	and	isomerization	of	disulfide	bonds.	
On	the	other	hand,	cytoplasmic	expression	is	the	usual	method	employed	in	the	Magliery	lab.	Venuka	Durani	decided	to	proceed	with	a	cytoplasmic	expression	scheme,	and	synthesized	the	WT	Er-23	gene	for	that	method.	The	OrigamiTM	B	(DE3)	E.	coli	strain	was	selected	as	the	expression	cell	line	to	aid	in	disulfide	formation.	The	WT	Er-
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23	gene	product	was	for	immobilized	metal	ion	affinity	chromatography	(IMAC)	purification.	Therefore,	the	protein	product	was	designed	to	have	an	N-terminal	6xHis-tag	that	would	be	cleaved	off	at	the	adjacent	TEV	protease	site.	These	features	were	followed	by	a	GSSG	linker,	and	then	the	WT	Er-23	protein.	The	GSSG	linker	was	added	under	the	assumption	that	it	would	aid	in	accessibility	of	the	TEV	site	by	TEV	protease.		
Early	attempts	at	protein	purification	optimization	were	fraught	with	confusion.	Coomassie	stain	is	the	standard	SDS-PAGE	protein	stain	in	the	Magliery	lab.	When	a	typical	protein	is	purified	using	our	protocol,	it	would	appear	uncleaved	in	the	pre-TEV	elution	lane,	then	separate	into	distinct	cleaved	protein	and	6xHis-tag	bands	in	the	post-TEV	lane,	and	finally	stain	as	purified	cleaved	protein	in	the	second	flow-through	lane.	However,	WT	Er-23	formed	one	distinct	band	in	the	post-TEV	lane	and	was	entirely	unseen	in	the	second	flow-through	lane.		
	
Figure	4.1:	Expected	vs.	Actual	Er-23	purification	SDS	gel	
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MALDI-TOF	mass	spectrometry	experiments	on	the	WT	Er-23	purification	samples	proved	the	presence	of	the	various	protein	products	in	their	respective	lanes,	based	on	predicted	mass.	The	mass	spectrum	below	shows	uncleaved	WT	Er-23	GSSG	(7393	Da)	in	the	pre-TEV	sample,	cleaved	6xHis-tag	(2075	Da)	in	the	post-TEV	sample,	and	cleaved	WT	Er-23	GSSG	(5336	Da)	in	the	post-TEV	and	flow-through	samples.	
	
Figure	4.2:	MALDI	spectra	of	preTEV	reaction	6xHis	WT	Er-23	GSSG	(7393	Da)	
	  26	
	
Figure	4.3:	MALDI	spectra	of	postTEV	reaction	6xHisTag	(2075	Da)	and	GSSG	WT	Er-23	(5336	Da)	
	
	
Figure	4.4:	MALDI	spectrum	of	the	second	flow-through	WT	Er-23	GSSG	(5336	Da)	
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	Alternate	SDS	gel	staining	procedures	were	attempted	to	produce	an	SDS	gel	with	cleaved	WT	Er-23	visualized.	The	typical	method	of	concentration	estimation	of	a	protein	sample	in	the	Magliery	lab	requires	a	quantitative	protein	staining	procedure,	such	as	Coomassie	stain.	The	only	successful	staining	method	we	found	was	silver	staining,	which	is	not	a	quantitative	stain.	The	pictures	below	are	replicate	SDS	gels	of	WT	Er-23	GSSG	purification	samples.	The	FT2	labels	on	the	gels	correspond	to	the	last	flow-through	of	the	protein	purification,	which	contains	the	purified	WT	Er-23	GSSG.	As	should	be	noted,	bands	appear	near	the	bottom	of	the	silver	stained	SDS	gel	in	the	post-TEV	and	FT2	lanes	that	are	not	visible	when	a	replicate	of	the	gel	was	stained	with	Coomassie.	This	experiment	provided	additional	verification	that	WT	Er-23	GSSG	was	purified	using	our	developed	protocol,	but	the	WT	Er-23	GSSG	was	not	binding	to	Coomassie	stain.	
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Figure	4.5:	Er-23	purification	SDS	gel	stained	with	Coomassie	vs.	Silver	Stain	
	
	 The	next	goal	in	the	project	was	to	find	a	method	to	confidently	estimate	the	concentration	of	Er-23	for	concentration-dependent	experiments,	since	Coomassie	and	other	quantitative	protein	stains	were	found	to	be	ineffective.	We	purified	a	large	master	stock	of	WT	Er-23	GSSG,	and	then	divided	it	into	three	aliquots.	One	of	the	aliquots	was	sent	to	Texas	A&M	University	for	amino	acid	analysis.	This	provided	us	with	the	estimated	concentration	of	master	stock	of	WT	Er-23	GSSG.		
From	the	second	aliquot	of	the	master	stock	a	1H	NMR	spectrum	was	acquired.	The	proton	NMR	signal	is	concentration-dependent,	so	the	peak	intensity	of	the	acquired	spectrum	reflects	the	concentration	of	WT	Er-23	GSSG	in	the	master	stock,	which	was	known	based	on	the	results	of	amino	acid	analysis	from	the	same	sample.	
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Figure	4.6:	WT	Er-23	GSSG	1H	NMR	Once	the	purification	issues	had	been	resolved,	we	were	able	to	shift	our	focus	to	characterization	of	Er-23.	The	major	characterization	goal	of	this	project	was	to	resolve	the	structure	of	Er-23	when	expressed	in	E.	coli,	and	compare	our	findings	to	the	previously	resolved	structure	of	Er-23	expressed	in	Euplotes	raikovi.	After	obtaining	the	proton	NMR	spectrum,	we	went	on	to	acquire	a	1H-15N	HSQC	NMR	of	WT	Er-23	GSSG	using	a	15N-labelled	sample.	The	1H-15N	HSQC	spectrum	contains	54	well-defined	cross-peaks,	which	were	assigned	by	David	Bowles.	Other	backbone	NMR	experiments	were	performed	such	as	HNCO,	HN(CA)CO,	HNCA,	and	HN(CO)CA.	Side-chain	experiments	were	performed	such	as	an	1H-13C	HSQC,	CC(CO)NH,	and	H(CCO)NH.	Additionally,	NOESY	experiments	were	performed,	which	will	lead	us	towards	solving	to	solution	structure.			
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Figure	4.7:	1H-15N	HSQC	NMR	of	WT	Er-23	GSSG	
	
Figure	4.8:	1H-13C	HSQC	NMR	of	WT	Er-23	GSSG	
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4.2:	Synthesis	and	Characterization	of	Cys-free	variants	
	 Former	undergraduate	researcher,	Kiersten	Lessig,	began	synthesis	of	the	Cys-free	variants.	Both	variants	for	the	3&24	and	6&16	disulfide	bonds	were	created.	These	variants	were	initially	made	because	computational	stability	analysis	(via	FoldX)	predicted	that	those	variants	would	have	stability	most	similar	to	WT	Er-2322.		These	Cys-free	variants	were	designed	without	the	GSSG	linker	that	was	used	in	the	wild-type	Er-23	construct	that	had	been	synthesized	and	partially	characterized22.	No	explanation	for	the	lack	of	GSSG	linker	was	provided.	Regardless	of	this	unresolved	issue,	we	decided	to	continue	synthesizing	the	Cys-free	variants	without	GSSG	linkers.		
	 Cys-free	variant	synthesis	has	been	completed	and	the	variants	have	been	analyzed	on	an	SDS	gel	for	expression	and	TEV	cleavage.	For	each	variant,	the	preTEV	and	postTEV	purification	fractions	are	analyzed.	We	look	for	the	6xHis-Er-23	band	in	the	preTEV	and	the	6xHis	band	running	higher	on	the	SDS	gel	in	the	postTEV	fraction,	as	is	seen	with	WT	Er-23	on	SDS	gels	when	stained	with	Coomassie.	Both	of	the	3&24	variants	do	not	appear	to	express	in	the	figure	below.	The	6&16	variants	are	being	expressed,	but	no	shift	in	banding	pattern	between	pre-	and	postTEV	fractions	is	observed,	indicating	that	the	variants	are	not	cleaved	by	TEV	protease.		
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Figure	4.9:	3&24	and	6&16	Er-23	Cys-free	variant	SDS	gel		
	 The	13&47,	27&40,	and	35&51	Cys-free	variant	purification	SDS	gel	is	pictured	below.	All	of	the	variants	below	have	an	obvious	shift	in	band	size	between	the	pre-	and	postTEV	fractions	similar	to	WT	Er-23	purification	fractions,	which	suggests	that	the	variants	of	these	three	disulfide	bonds	are	capable	of	expressing	in	E.	coli	and	cleaving	with	TEV	protease	using	our	protocol.	
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Figure	4.10:	13&47,	27&40,	and	35&51	Er-23	Cys-free	SDS	gel		 	
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Chapter	5	
	Discussion	and	Future	Work	
In	this	project,	we	have	performed	a	series	of	experiments	that	provide	evidence	suggesting	successful	heterologous	expression	of	Er-23	in	Escherichia	coli.	MALDI	Mass	Spectroscopy	spectra	of	Er-23	purification	fractions	indicate	that	the	products	of	protein	expression	and	purification	are	present	in	their	expected	purification	fractions	based	on	predicted	size.	Circular	dichroism	studies	of	WT	Er-23	reveal	signal	in	the	210-220	nm	range	indicates	the	formation	of	alpha-helical	structure	in	the	protein,	and	the	dampened	signal	indicates	the	presence	of	disulfide	bonds.	Additionally,	the	CD	spectra	of	Er-23	from	homologous	expression	is	similar	to	that	from	E.	coli,	which	can	be	evidence	of	correct	folding	of	Er-23	in	E.	coli.	Furthermore,	similarity	of	thermal	melt	CD	spectra	between	homologously-	and	heterologously-expressed	Er-23	is	evidence	that	the	Er-23	is	adopting	a	wild-type	fold	and	therefore	wild-type	thermal	stability,	when	expressed	in	E.	coli.	Finally,	NMR	studies	provide	evidence	of	well-folded	structure	of	heterologously-expressed	WT	Er-23	due	to	well	defined	peaks	in	1H	NMR	and	well	defined	cross	peaks	in	1H-15N	HSQC	NMR.	The	combination	of	this	evidence	supports	the	conclusion	that	Er-23,	a	small	disulfide-rich	protein,	is	folding	into	the	wild-type	conformation	when	expressed	in	the	cytoplasm	of	Escherichia	coli.		
The	NMR	solution	structure	of	heterologously-expressed	WT	Er-23	GSSG	is	being	calculated	during	the	writing	of	this	thesis.	Upon	resolution	of	the	solution	structure,	comparison	of	heterologous	Er-23	structure	and	homologous	Er-23	structure	
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will	confirm	whether	heterologous	Er-23	is	adopting	wild-type	fold	when	expressed	in	typically	unfavorable	conditions.	If	the	protein	is	adopting	the	wild-type	fold,	our	experiment	gives	us	the	ability	to	solve	a	much	more	constrained	NMR	solution	structure	for	Er-23	than	previously	done	given	the	isotopically	labeled	Er-23	used	in	our	experiments.	Additionally,	completion	of	the	Anfinsen	experiment	on	WT	Er-23	will	provide	some	evidence	for	what	is	driving	its	fold:	amino	acid	sequence	or	disulfide	formation.		
The	goal	of	synthesizing	and	characterizing	the	Er-23	Cys-free	variants	is	well	underway.	All	ten	variants	have	been	synthesized,	and	five	of	them	are	capable	of	expression	and	TEV	cleavage	as	determined	on	an	SDS	gel.	The	3&24	Cys-free	variants	are	unable	to	be	expressed	based	on	our	protocol,	which	may	suggest	that	this	disulfide	bond	is	critical	to	the	protein,	expression	optimization	is	required,	or	that	the	variants	provided	are	in	some	way	flawed.	The	6&16	Cys-free	variants	are	capable	of	expression,	but	not	able	to	be	TEV	cleaved.	This	could	suggest	that	steric	occlusion	of	the	TEV	site	is	obstructing	the	access	of	TEV	protease	to	its	substrate	(TEV	site).	The	addition	of	a	GSSG	linker	in	the	6&16	Cys-free	construct	could	improve	TEV	protease	access.		
Future	work	on	the	Cys-free	variants	should	be	focused	on	purification/expression	optimization	and	characterization.	Purification	and	expression	optimization	is	needed	to	determine	how	many	of	the	Cys-free	variants	are	capable	of	expressing	in	E.	coli,	which	can	provide	initial	evidence	for	the	contribution	of	each	disulfide	to	the	wild-type	fold.	MALDI	spectra	of	purification	fractions	of	the	variants	should	be	obtained	to	confirm	the	presence	of	expected	protein	products	in	each	
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fraction	by	mass.	Finally,	Cys-free	variant	structure	analysis	should	be	performed	and	compared	to	WT	Er-23.	CD	spectra	should	be	obtained	to	investigate	the	formation	of	secondary	structure	and	disulfide	bonds.	Thermal	melts	may	also	be	performed	to	compare	Cys-free	thermal	stability	to	WT	Er-23.	Alternatively,	1H	or	1H-15N	NMR	spectra	of	the	Cys-free	variants	can	be	obtained	to	assess	whether	they	are	well-folded.	Evidence	from	the	Cys-free	variant	structural	studies	will	allow	us	to	determine	the	contribution	and	importance	of	each	disulfide	bond	in	the	fold	and	stability	of	WT	Er-23.	The	investigation	of	disulfide	contribution	to	the	fold	of	Er-23	will	allow	us	to	assess	whether	the	fold	is	determined	by	the	disulfides	as	previously	predicted1,	or	by	the	amino	acid	sequence	as	hypothesized	by	Anfinsen5,6.	
			
	 	
	  37	
References	1.	 Zahn,	R.,	Damberger,	F.,	Ortenzi,	C.,	Luporini,	P.	&	Wüthrich,	K.	NMR	structure	of	the	Euplotes	raikovi	pheromone	Er-23	and	identification	of	its	five	disulfide	bonds.	J.	Mol.	Biol.	313,	923–31	(2001).	2.	 Levinthal,	C.	How	to	fold	graciously.	Mössbauer	Spectrosc.	Biol.	Syst.	Proc.	24,	22–24	(1969).	3.	 Anfinsen,	C.	B.	The	Formation	and	Stabilization	of	Protein	Structure.	Biochem.	J.	
128,	737–749	(1972).	4.	 Anfinsen,	C.	B.	&	Haber,	E.	ARTICLE :	Studies	on	the	Reduction	and	Re-formation	of	Protein	Disulfide	Bonds	Studies	on	the	Reduction	and	Re-formation	of	Protein	Disulfide	Bonds.	1361–1363	(1961).	5.	 Kresge,	N.,	Simoni,	R.	D.	&	Hill,	L.	Work	of	Christian	Anfinsen.	(2006).	6.	 Anfinsen,	C.	B.	Principles	that	Govern	the	Folding	of	Protein	Chains.	Science	(80-.	).	
181,	223–230	(1973).	7.	 Levinthal,	C.	Are	there	pathways	for	protein	folding?	J.	Chim.	Phys.	Physico-Chimie	
Biol.	65,	44–45	(1968).	8.	 Zwanzig,	R.,	Szabo,	A.	&	Bagchi,	B.	Levinthal	’	s	paradox.	89,	20–22	(1992).	9.	 Dill,	K.	A.	Dominant	Forces	in	Protein	Folding	Ken.	29,	(1990).	10.	 Durup,	J.	(Universite	P.	S.	et	C.	On	‘Levinthal	paradox’	and	the	theory	of	protein	folding.	J.	Mol.	Struct.	424,	157–169	(1998).	11.	 Arolas,	J.	L.,	Aviles,	F.	X.,	Chang,	J.	Y.	&	Ventura,	S.	Folding	of	small	disulfide-rich	proteins:	clarifying	the	puzzle.	Trends	Biochem.	Sci.	31,	292–301	(2006).	12.	 Depuydt,	M.,	Messens,	J.	&	Collet,	J.-F.	How	proteins	form	disulfide	bonds.	
Antioxid.	Redox	Signal.	15,	49–66	(2011).	13.	 Bessette,	P.	H.,	Aslund,	F.,	Beckwith,	J.	&	Georgiou,	G.	Efficient	folding	of	proteins	with	multiple	disulfide	bonds	in	the	Escherichia	coli	cytoplasm.	Proc.	Natl.	Acad.	
Sci.	U.	S.	A.	96,	13703–13708	(1999).	14.	 Bulaj,	G.	Formation	of	disulfide	bonds	in	proteins	and	peptides.	Biotechnol.	Adv.	
23,	87–92	(2005).	15.	 Kabashima,	T.,	Li,	Y.,	Kanada,	N.,	Ito,	K.	&	Yoshimoto,	T.	Enhancement	of	the	thermal	stability	of	pyroglutamyl	peptidase	I	by	introduction	of	an	intersubunit	disulfide	bond.	Biochim.	Biophys.	Acta	-	Protein	Struct.	Mol.	Enzymol.	1547,	214–220	(2001).	
	  38	
16.	 Han,	Z.	L.,	Han,	S.	Y.,	Zheng,	S.	P.	&	Lin,	Y.	Enhancing	thermostability	of	a	Rhizomucor	miehei	lipase	by	engineering	a	disulfide	bond	and	displaying	on	the	yeast	cell	surface.	Appl.	Microbiol.	Biotechnol.	85,	117–126	(2009).	17.	 Bjørk,	A.,	Dalhus,	B.,	Mantzilas,	D.,	Eijsink,	V.	G.	H.	&	Sirevåg,	R.	Stabilization	of	a	tetrameric	malate	dehydrogenase	by	introduction	of	a	disulfide	bridge	at	the	dimer-dimer	interface.	J.	Mol.	Biol.	334,	811–821	(2003).	18.	 Luporini,	P.,	Alimenti,	C.,	Ortenzi,	C.	&	Vallesi,	A.	Ciliate	mating	types	and	their	specific	protein	pheromones.	Acta	Protozool.	44,	89–101	(2005).	19.	 Di,	G.	G.	et	al.	A	structurally	deviant	member	of	the	Euplotes	raikovi	pheromone	family:	Er-23.	J.	Eukaryot.	Microbiol.	49,	86–92	(2002).	20.	 Vallesi,	A.	et	al.	Autocrine,	mitogenic	pheromone	receptor	loop	of	the	ciliate	Euplotes	raikovi:	Pheromone-induced	receptor	internalization.	Eukaryot.	Cell	4,	1221–1227	(2005).	21.	 Geralt,	M.,	Alimenti,	C.,	Vallesi,	A.,	Luporini,	P.	&	Wüthrich,	K.	Thermodynamic	stability	of	psychrophilic	and	mesophilic	pheromones	of	the	protozoan	ciliate	euplotes.	Biology	(Basel).	2,	142–50	(2013).	22.	 Lessig,	K.	L.	Towards	the	flip	of	FruR	to	Er23	via	Disulfide	Bond	Modification.	(2014).	23.	 Concetti,	A.,	Raffioni,	S.,	Miceli,	C.,	Barras,	D.	&	Luporini,	P.	Purification	to	Apparent	Homogeneity	of	the	Mating	Pheromone	of	mat-1	Homozygous	Euplotes	raikovP.	261,	10582–10586	(1986).	24.	 Gebendorfer,	K.	&	Winter,	J.	in	Oxidative	Fold.	Pept.	Proteins	43	(Royal	Society	of	Chemistry,	2009).	25.	 Hari,	S.	B.,	Byeon,	C.,	Lavinder,	J.	J.	&	Magliery,	T.	J.	Cysteine-free	Rop:	A	four-helix	bundle	core	mutant	has	wild-type	stability	and	structure	but	dramatically	different	unfolding	kinetics.	Protein	Sci.	19,	670–679	(2010).	26.	 Lepock,	R.,	Frey,	E.	&	Hallewellj,	A.	Contribution	of	Conformational	Stability	and	Reversibility	of	Unfolding	to	the	Increased	Thermostability	of	Human	and	Bovine	Superoxide	Dismutase	Mutated	at	Free	Cysteines	*	C ;;“(	T	)	=	AHcg.	265,	21612–21619	(1990).	27.	 Magliery,	T.	J.	&	Regan,	L.	A	cell-based	screen	for	function	of	the	four-helix	bundle	protein	Rop :	a	new	tool	for	combinatorial	experiments	in	biophysics.	17,	77–83	(2004).	28.	 Durani,	V.	The	Cycle	of	Protein	Engineering:	Bioinformatics	Design	of	Two	Dimeric	Proteins	and	Computational	Design	of	a	Small	Globular	Domain.	PhD	
Propos.	1,	(2012).	
	  39	
29.	 70837	|	OrigamiTM	B(DE3)	Competent	Cells	-	Novagen.	EMD	Millipore	(2016).					
